GPGrossPatternRESEARCH SYSTEM
SEC CHECK OPERATIONAL
GROSSPATTERN / FUNDAMENTAL STATE / POINT IN TIME

ENSC · Sep 30, 2025

Ensysce Biosciences, Inc.. A multidimensional configuration derived from the filing available at this observation—never a composite score or recommendation.

STATE CAPABILITYLEVEL 3[email protected]
Inspectable configuration

State dimensions

Filing0001493152-25-023498General Corporate
Operating cash generation69thOwn-history percentile · N=13
Evidence method

Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue

-378.46% · OPTIONAL · VALID

Revenue growth0thOwn-history percentile · N=9
Evidence method

Yoy · gp.fundamentals.revenue

-85.58% · CORE · VALID

Operating margin31thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.operating_margin

-758.68% · CORE · VALID

R&D intensity77thOwn-history percentile · N=13
Evidence method

Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue

599.25% · OPTIONAL · VALID

SBC intensity31thOwn-history percentile · N=13
Evidence method

Level · gp.fundamentals.sbc_revenue_ratio

9.30% · OPTIONAL · VALID

As-filed lineage

Fundamental state history

Each observation is tied to the filing and facts available at that report date. Amendments remain separate.

History13 statesSelf-history eligible
Period transition

What moved in the state?

Cash Generation Decreased
Previous
-197.37%
Current
-378.46%
Delta
-181.08%
Growth Decreased
Previous
654.38%
Current
-85.58%
Delta
-739.96%
Profitability Decreased
Previous
-127.64%
Current
-758.68%
Delta
-631.04%
R And D Intensity Increased
Previous
140.25%
Current
599.25%
Delta
459.00%
Sbc Intensity Increased
Previous
6.61%
Current
9.30%
Delta
2.69%
Self-history only

Previous similar states

Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.

Not enough compatible prior states for a transparent self-history match.
Research Graph

Related governed research

Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.